CDT1 and neoplasm: Combining the best chemotherapeutic action with specific targets in cellular pathways offers a powerful new approach to cancer treatment that might counteract the many ways that human cells can become drug-resistant, while Cdt1 targeting might be per se essential as a factor promoting tumor development.